Wasatch Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-448,539
Closed -$5.83M 248
2025
Q2
$5.83M Buy
448,539
+65,052
+17% +$978K 0.03% 181
2025
Q1
$9.68M Buy
383,487
+72,891
+23% +$2.17M 0.05% 158
2024
Q4
$10.7M Buy
310,596
+103,856
+50% +$4.68M 0.05% 156
2024
Q3
$10.2M Buy
206,740
+66,887
+48% +$3.43M 0.05% 156
2024
Q2
$8.41M Buy
+139,853
New +$7.99M 0.05% 164

Other funds holding RXST

Wasatch Advisors's RXST Position: Q3 2025 in Review

Wasatch Advisors sold out of RxSight (RXST) in Q3 2025, closing a stake of 448,539 shares — an estimated $5.83M sold.

Wasatch Advisors first reported a position in RXST in Q2 2024 and held it in 5 quarters. The position peaked at $10.7M in Q4 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Wasatch Advisors reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • Wasatch Advisors sold 448,539 RxSight shares in Q3 2025, an estimated $5.83M.
  • Wasatch Advisors first reported a position in RxSight in Q2 2024 and held it in 5 quarters.
  • Wasatch Advisors's RxSight position peaked at $10.7M in Q4 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Wasatch Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.